While co-occurrence of MPS II and biotinidase deficiency may complicate phenotypic interpretation and highlights the importance of comprehensive genetic profiling, only a single pathogenic variant was identified in this gene. This evidence concerns the gene BTD and mucopolysaccharidosis type 2.